380 related articles for article (PubMed ID: 22389337)
1. Cost effectiveness of strategies to combat cardiovascular disease, diabetes, and tobacco use in sub-Saharan Africa and South East Asia: mathematical modelling study.
Ortegón M; Lim S; Chisholm D; Mendis S
BMJ; 2012 Mar; 344():e607. PubMed ID: 22389337
[TBL] [Abstract][Full Text] [Related]
2. Cost effectiveness of strategies to combat breast, cervical, and colorectal cancer in sub-Saharan Africa and South East Asia: mathematical modelling study.
Ginsberg GM; Lauer JA; Zelle S; Baeten S; Baltussen R
BMJ; 2012 Mar; 344():e614. PubMed ID: 22389347
[TBL] [Abstract][Full Text] [Related]
3. Cost effectiveness of strategies to combat chronic obstructive pulmonary disease and asthma in sub-Saharan Africa and South East Asia: mathematical modelling study.
Stanciole AE; Ortegón M; Chisholm D; Lauer JA
BMJ; 2012 Mar; 344():e608. PubMed ID: 22389338
[TBL] [Abstract][Full Text] [Related]
4. Cost effectiveness of strategies to combat neuropsychiatric conditions in sub-Saharan Africa and South East Asia: mathematical modelling study.
Chisholm D; Saxena S
BMJ; 2012 Mar; 344():e609. PubMed ID: 22389339
[TBL] [Abstract][Full Text] [Related]
5. Cost effectiveness of strategies to combat road traffic injuries in sub-Saharan Africa and South East Asia: mathematical modelling study.
Chisholm D; Naci H; Hyder AA; Tran NT; Peden M
BMJ; 2012 Mar; 344():e612. PubMed ID: 22389340
[TBL] [Abstract][Full Text] [Related]
6. Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries.
Hogan DR; Baltussen R; Hayashi C; Lauer JA; Salomon JA
BMJ; 2005 Dec; 331(7530):1431-7. PubMed ID: 16282380
[TBL] [Abstract][Full Text] [Related]
7. Cost effectiveness of strategies to combat vision and hearing loss in sub-Saharan Africa and South East Asia: mathematical modelling study.
Baltussen R; Smith A
BMJ; 2012 Mar; 344():e615. PubMed ID: 22389341
[TBL] [Abstract][Full Text] [Related]
8. Global and regional estimates of the effectiveness and cost-effectiveness of price increases and other tobacco control policies.
Ranson MK; Jha P; Chaloupka FJ; Nguyen SN
Nicotine Tob Res; 2002 Aug; 4(3):311-9. PubMed ID: 12215240
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of malaria control in sub-Saharan Africa.
Goodman CA; Coleman PG; Mills AJ
Lancet; 1999 Jul; 354(9176):378-85. PubMed ID: 10437867
[TBL] [Abstract][Full Text] [Related]
10. Cost effectiveness analysis of strategies for tuberculosis control in developing countries.
Baltussen R; Floyd K; Dye C
BMJ; 2005 Dec; 331(7529):1364. PubMed ID: 16282379
[TBL] [Abstract][Full Text] [Related]
11. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I
Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749
[TBL] [Abstract][Full Text] [Related]
12. Cost effectiveness analysis of strategies for maternal and neonatal health in developing countries.
Adam T; Lim SS; Mehta S; Bhutta ZA; Fogstad H; Mathai M; Zupan J; Darmstadt GL
BMJ; 2005 Nov; 331(7525):1107. PubMed ID: 16282407
[TBL] [Abstract][Full Text] [Related]
13. Estimated effect of increased diagnosis, treatment, and control of diabetes and its associated cardiovascular risk factors among low-income and middle-income countries: a microsimulation model.
Basu S; Flood D; Geldsetzer P; Theilmann M; Marcus ME; Ebert C; Mayige M; Wong-McClure R; Farzadfar F; Saeedi Moghaddam S; Agoudavi K; Norov B; Houehanou C; Andall-Brereton G; Gurung M; Brian G; Bovet P; Martins J; Atun R; Bärnighausen T; Vollmer S; Manne-Goehler J; Davies J
Lancet Glob Health; 2021 Nov; 9(11):e1539-e1552. PubMed ID: 34562369
[TBL] [Abstract][Full Text] [Related]
14. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.
Eaton JW; Menzies NA; Stover J; Cambiano V; Chindelevitch L; Cori A; Hontelez JA; Humair S; Kerr CC; Klein DJ; Mishra S; Mitchell KM; Nichols BE; Vickerman P; Bakker R; Bärnighausen T; Bershteyn A; Bloom DE; Boily MC; Chang ST; Cohen T; Dodd PJ; Fraser C; Gopalappa C; Lundgren J; Martin NK; Mikkelsen E; Mountain E; Pham QD; Pickles M; Phillips A; Platt L; Pretorius C; Prudden HJ; Salomon JA; van de Vijver DA; de Vlas SJ; Wagner BG; White RG; Wilson DP; Zhang L; Blandford J; Meyer-Rath G; Remme M; Revill P; Sangrujee N; Terris-Prestholt F; Doherty M; Shaffer N; Easterbrook PJ; Hirnschall G; Hallett TB
Lancet Glob Health; 2014 Jan; 2(1):e23-34. PubMed ID: 25104632
[TBL] [Abstract][Full Text] [Related]
15. Estimation of the burden of cardiovascular disease attributable to modifiable risk factors and cost-effectiveness analysis of preventative interventions to reduce this burden in Argentina.
Rubinstein A; Colantonio L; Bardach A; Caporale J; Martí SG; Kopitowski K; Alcaraz A; Gibbons L; Augustovski F; Pichón-Rivière A
BMC Public Health; 2010 Oct; 10():627. PubMed ID: 20961456
[TBL] [Abstract][Full Text] [Related]
16. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.
Marseille E; Kahn JG; Mmiro F; Guay L; Musoke P; Fowler MG; Jackson JB
Lancet; 1999 Sep; 354(9181):803-9. PubMed ID: 10485721
[TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness of Population Level and Individual Level Interventions to Combat Non-communicable Disease in Eastern Sub-Saharan Africa and South East Asia: A WHO-CHOICE Analysis.
Bertram MY; Chisholm D; Watts R; Waqanivalu T; Prasad V; Varghese C
Int J Health Policy Manag; 2021 Nov; 10(11):724-733. PubMed ID: 34273918
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of medical primary prevention strategies to reduce absolute risk of cardiovascular disease in Tanzania: a Markov modelling study.
Ngalesoni FN; Ruhago GM; Mori AT; Robberstad B; Norheim OF
BMC Health Serv Res; 2016 May; 16():185. PubMed ID: 27184802
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of a fixed-dose combination pill for secondary prevention of cardiovascular disease in China, India, Mexico, Nigeria, and South Africa: a modelling study.
Lin JK; Moran AE; Bibbins-Domingo K; Falase B; Pedroza Tobias A; Mandke CN; Kazi DS
Lancet Glob Health; 2019 Oct; 7(10):e1346-e1358. PubMed ID: 31477544
[TBL] [Abstract][Full Text] [Related]
20. Cost effectiveness of a government supported policy strategy to decrease sodium intake: global analysis across 183 nations.
Webb M; Fahimi S; Singh GM; Khatibzadeh S; Micha R; Powles J; Mozaffarian D
BMJ; 2017 Jan; 356():i6699. PubMed ID: 28073749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]